These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 33752302)
21. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. Starke RM; Raper DM; Payne SC; Vance ML; Oldfield EH; Jane JA J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas. Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759 [TBL] [Abstract][Full Text] [Related]
23. [Outcome of surgical treatment for acromegaly performed by a single neurosurgeon and cumulative meta-analysis]. Boeving A; Borba LA; Rodrigues AM; Orichowski EB; Paz Filho GJ; Santos CM; Boguszewski CL Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):884-92. PubMed ID: 17160212 [TBL] [Abstract][Full Text] [Related]
24. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Campbell PG; Kenning E; Andrews DW; Yadla S; Rosen M; Evans JJ Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130 [TBL] [Abstract][Full Text] [Related]
25. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays. Sarkar S; Jacob KS; Pratheesh R; Chacko AG Acta Neurochir (Wien); 2014 Jul; 156(7):1379-87; discussion 1387. PubMed ID: 24781680 [TBL] [Abstract][Full Text] [Related]
27. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly. Cardinal T; Collet C; Wedemeyer M; Singer PA; Weiss M; Zada G; Carmichael JD Front Endocrinol (Lausanne); 2021; 12():743052. PubMed ID: 34867787 [TBL] [Abstract][Full Text] [Related]
28. Predictors of Remission of Acromegaly following Surgical Treatment in Growth Hormone-Secreting Pituitary Adenoma. Konar S; Yeole U; Shukla D; Bhat DI; Sadashiva N; Devi BI J Neurol Surg B Skull Base; 2024 Jun; 85(3):261-266. PubMed ID: 38721370 [No Abstract] [Full Text] [Related]
29. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation. Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774 [TBL] [Abstract][Full Text] [Related]
30. SIGNIFICANT ELEVATION OF GROWTH HORMONE LEVEL IMPACTS SURGICAL OUTCOMES IN ACROMEGALY. Anthony JR; Alwahab UA; Kanakiya NK; Pontell DM; Veledar E; Oyesiku NM; Ioachimescu AG Endocr Pract; 2015 Sep; 21(9):1001-9. PubMed ID: 26121434 [TBL] [Abstract][Full Text] [Related]
31. GNAS imprinting and pituitary tumors. Mantovani G; Lania AG; Spada A Mol Cell Endocrinol; 2010 Sep; 326(1-2):15-8. PubMed ID: 20398730 [TBL] [Abstract][Full Text] [Related]
32. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria. Anik I; Cabuk B; Gokbel A; Selek A; Cetinarslan B; Anik Y; Ceylan S World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283 [TBL] [Abstract][Full Text] [Related]
33. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly. Jung IH; Choi S; Ku CR; Lee SG; Lee EJ; Kim SH; Kim EH J Clin Endocrinol Metab; 2021 Jun; 106(7):e2589-e2599. PubMed ID: 33738470 [TBL] [Abstract][Full Text] [Related]
35. Delayed Remission of Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Adenectomy. Wang Z; Guo X; Gao L; Feng C; Lian W; Deng K; Bao X; Feng M; Wang R; Xing B World Neurosurg; 2019 Feb; 122():e1137-e1145. PubMed ID: 30447463 [TBL] [Abstract][Full Text] [Related]
36. Surgical and endocrinological outcomes in the treatment of growth hormone-secreting pituitary adenomas according to the shift of surgical paradigm. Ku CR; Kim EH; Oh MC; Lee EJ; Kim SH Neurosurgery; 2012 Dec; 71(2 Suppl Operative):ons192-203; discussion ons203. PubMed ID: 22743357 [TBL] [Abstract][Full Text] [Related]
37. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly. Kim EH; Oh MC; Lee EJ; Kim SH Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418 [TBL] [Abstract][Full Text] [Related]
38. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. Almeida JP; Ruiz-Treviño AS; Liang B; Omay SB; Shetty SR; Chen YN; Anand VK; Grover K; Christos P; Schwartz TH J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548 [TBL] [Abstract][Full Text] [Related]
39. 3D Volumetric Measurements of GH Secreting Adenomas Correlate with Baseline Pituitary Function, Initial Surgery Success Rate, and Disease Control. Tirosh A; Papadakis GZ; Chittiboina P; Lyssikatos C; Belyavskaya E; Keil M; Lodish MB; Stratakis CA Horm Metab Res; 2017 Jun; 49(6):440-445. PubMed ID: 28472827 [TBL] [Abstract][Full Text] [Related]
40. Outcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus Invasion. Park HH; Kim EH; Ku CR; Lee EJ; Kim SH World Neurosurg; 2018 Sep; 117():e280-e289. PubMed ID: 29906579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]